Commentary on "Progress in the management of type 2 diabetes mellitus: a narrative review of telerehabilitation and wearable devices".
作者信息
Kim Ji Hyun
机构信息
Department of Pediatrics, Dongguk University Ilsan Hospital, Goyang, Korea.
出版信息
Ann Pediatr Endocrinol Metab. 2025 Apr;30(2):57-58. doi: 10.6065/apem.2524081edi02. Epub 2025 Apr 30.
Abstract
摘要
相似文献
1
Commentary on "Progress in the management of type 2 diabetes mellitus: a narrative review of telerehabilitation and wearable devices".《2型糖尿病管理进展：远程康复与可穿戴设备的叙述性综述》述评
Ann Pediatr Endocrinol Metab. 2025 Apr;30(2):57-58. doi: 10.6065/apem.2524081edi02. Epub 2025 Apr 30.
2
Progress in the management of type 2 diabetes mellitus: a narrative review of telerehabilitation and wearable devices.2型糖尿病管理的进展：远程康复与可穿戴设备的叙述性综述
Ann Pediatr Endocrinol Metab. 2025 Apr;30(2):69-76. doi: 10.6065/apem.2448162.081. Epub 2025 Apr 30.
3
[Progress in the Application of Wearable Devices in Patients With Type 2 Diabetes Mellitus].[可穿戴设备在2型糖尿病患者中的应用进展]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Oct;46(5):769-775. doi: 10.3881/j.issn.1000-503X.15869.
4
Role of wearable devices in cardiac telerehabilitation: A scoping review.可穿戴设备在心脏远程康复中的作用：范围综述。
PLoS One. 2023 May 31;18(5):e0285801. doi: 10.1371/journal.pone.0285801. eCollection 2023.
5
Usability of a wearable device for home-based upper limb telerehabilitation in persons with stroke: A mixed-methods study.用于中风患者家庭上肢远程康复的可穿戴设备的可用性：一项混合方法研究。
Digit Health. 2023 Feb 7;9:20552076231153737. doi: 10.1177/20552076231153737. eCollection 2023 Jan-Dec.
6
[Consensus on collaborative ethical review of multi-center clinical trials of new drugs of traditional Chinese medicine (version 1.0)].《中药新药多中心临床试验合作伦理审查共识（试行）》
Zhongguo Zhong Yao Za Zhi. 2021 Apr;46(7):1696-1700. doi: 10.19540/j.cnki.cjcmm.20210304.501.
7
Effectiveness of home-based cardiac telerehabilitation based on wearable ECG or heart rate monitoring devices in patients with heart disease: A meta-analysis of randomized controlled trials.基于可穿戴心电图或心率监测设备的家庭心脏远程康复在心脏病患者中的有效性：一项随机对照试验的荟萃分析。
Geriatr Nurs. 2024 Jul-Aug;58:238-246. doi: 10.1016/j.gerinurse.2024.05.036. Epub 2024 Jun 4.
8
[Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].关于“系列方剂”同步转化创新中药研发与注册路径的思考
Zhongguo Zhong Yao Za Zhi. 2022 Feb;47(4):1120-1125. doi: 10.19540/j.cnki.cjcmm.20211027.501.
9
Balance telerehabilitation and wearable technology for people with Parkinson's disease (TelePD trial).平衡远程康复和可穿戴技术在帕金森病患者中的应用（TelePD 试验）。
BMC Neurol. 2023 Oct 13;23(1):368. doi: 10.1186/s12883-023-03403-3.
10
CNT/Graphite/SBS Conductive Fibers for Strain Sensing in Wearable Telerehabilitation Devices.用于可穿戴远程康复设备应变传感的 CNT/石墨/SBS 导电纤维。
Sensors (Basel). 2022 Jan 21;22(3):800. doi: 10.3390/s22030800.
本文引用的文献
1
Progress in the management of type 2 diabetes mellitus: a narrative review of telerehabilitation and wearable devices.2型糖尿病管理的进展：远程康复与可穿戴设备的叙述性综述
Ann Pediatr Endocrinol Metab. 2025 Apr;30(2):69-76. doi: 10.6065/apem.2448162.081. Epub 2025 Apr 30.
2
7. Diabetes Technology: Standards of Care in Diabetes-2024.7. 糖尿病技术：2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007.
3
Efficiency of an mHealth App and Chest-Wearable Remote Exercise Monitoring Intervention in Patients With Type 2 Diabetes: A Prospective, Multicenter Randomized Controlled Trial.一款移动医疗应用程序和胸部可穿戴远程运动监测干预在 2 型糖尿病患者中的应用效率：一项前瞻性、多中心随机对照试验。
JMIR Mhealth Uhealth. 2021 Feb 9;9(2):e23338. doi: 10.2196/23338.
4
Disparities in the use of a mHealth medication adherence promotion intervention for low-income adults with type 2 diabetes.针对低收入2型糖尿病成年患者的移动健康药物依从性促进干预措施使用方面的差异。
J Am Med Inform Assoc. 2016 Jan;23(1):12-8. doi: 10.1093/jamia/ocv082. Epub 2015 Jul 17.
5
Healthcare in the pocket: mapping the space of mobile-phone health interventions.口袋里的医疗保健：手机健康干预措施的空间映射。
J Biomed Inform. 2012 Feb;45(1):184-98. doi: 10.1016/j.jbi.2011.08.017. Epub 2011 Sep 9.
6
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较（英国前瞻性糖尿病研究[UKPDS 33]）。英国前瞻性糖尿病研究（UKPDS）小组
Lancet. 1998 Sep 12;352(9131):837-53.
Zotero 插件